Reconstituted HDL increases circulating endothelial progenitor cells in patients with type 2 diabetes.
van Oostrom
O
O
Nieuwdorp
M
M
Westerweel
P E
PE
Hoefer
I E
IE
Basser
R
R
Stroes
E S G
ES
Verhaar
M C
MC
D000704:Analysis of Variance; D002465:Cell Movement / Q000502:physiology; D049109:Cell Proliferation / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000503:physiopathology; D042783:Endothelial Cells / Q000187:drug effects* / Q000502:physiology; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007262:Infusions, Intravenous; D008075:Lipoproteins, HDL / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011336:Probability; D012494:Sampling Studies; D012680:Sensitivity and Specificity; D013234:Stem Cells / Q000187:drug effects* / Q000502:physiology
D008075:Lipoproteins, HDL